Market Place
Sourcing Support
Sionna Doses In Ph1 Trial Of SION-451 For Cystic Fibrosis
25 Aug 2025 //
GLOBENEWSWIRE
Sionna Therapeutics Presents Data on Dual CFTR Correction Therapy
06 Jun 2025 //
GLOBENEWSWIRE
Sionna Advances SION-719, SION-451 After Positive Ph1 CF Data
04 Jun 2025 //
GLOBENEWSWIRE
Sionna Therapeutic at Goldman Sachs 46th Annual Health Conference
03 Jun 2025 //
GLOBENEWSWIRE
Sionna to Present Cystic Fibrosis Data at European Conference
22 May 2025 //
GLOBENEWSWIRE
Sionna Therapeutics Reports First Quarter 2025 Financial Results
12 May 2025 //
GLOBENEWSWIRE
Sionna to Present at Citizens Life Sciences Conf. 2025
30 Apr 2025 //
GLOBENEWSWIRE
Sionna Therapeutics Reports Q4 2024 Financial Results
20 Mar 2025 //
GLOBENEWSWIRE
Sionna’s NBD1 Stabilisers May Differ From Vertex’s CF Treatment
02 Mar 2025 //
EXPRESSPHARMA
Sionna’s NBD1 Stabilisers Aim to Differ From Vertex’s CF Therapies
28 Feb 2025 //
EXPRESS PHARMA
Sionna Therapeutics at 45th Annual TD Cowen Health Care Conf.
24 Feb 2025 //
GLOBENEWSWIRE
Sionna Closes $219.2M IPO, Underwriters` Option Exercised
10 Feb 2025 //
GLOBENEWSWIRE
Vertex challenger Sionna prices $191M IPO
06 Feb 2025 //
BIOPHARMADIVE
Sionna Adds Dr. Marcella & Dr. Jo Viney to Board of Directors
08 Jan 2025 //
PR NEWSWIRE
Sionna Therapeutics Appoints Laurie Stelzer to Board of Directors
18 Nov 2024 //
PR NEWSWIRE
TPG tops up funds to $580M for investments across the life sciences spectrum
06 Aug 2024 //
FIERCE BIOTECH
Sionna Licenses Abbvie Assets to Advance Cystic Fibrosis Treatments
30 Jul 2024 //
CONTRACT PHARMA
Sionna salvages AbbVie assets for assault on cystic fibrosis
16 Jul 2024 //
FIERCE BIOTECH
Sionna Therapeutics Licenses CF Compounds From AbbVie
16 Jul 2024 //
PR NEWSWIRE
Sionna Appoints Jennifer Fitzpatrick As General Counsel
03 Jun 2024 //
PR NEWSWIRE
Sionna adds $182M to extend pipeline, cash runway through 2026
06 Mar 2024 //
FIERCE BIOTECH
Sionna Therapeutics Announces Phase 1 Initiation for SION-109 in Cystic Fibrosis
24 Jan 2024 //
PR NEWSWIRE
Sionna Therapeutics to Present Updates on Clinical Progress in Cystic Fibrosis
03 Jan 2024 //
PR NEWSWIRE
Sionna Presents Data at 2023 North American Cystic Fibrosis Conference
03 Nov 2023 //
PR NEWSWIRE
Sionna Therapeutics to Present at 2023 North American Cystic Fibrosis Conference
18 Oct 2023 //
PR NEWSWIRE
Sionna Therapeutics Announces Advancement of Cystic Fibrosis Pipeline Programs
05 Jan 2023 //
PR NEWSWIRE
Sionna Therapeutics Announces IND Clearance and Phase 1 Initiation for SION-638
07 Dec 2022 //
PRNEWSWIRE
Sionna Therapeutics Appoints Vanya Sagar as CPO
14 Nov 2022 //
BIOSPACE
Sionna Therapeutics Announces Appointment of Vanya Sagar as Chief People Officer
14 Nov 2022 //
PRNEWSWIRE
Sionna Therapeutics Announces Formation of Scientific Advisory Board
01 Aug 2022 //
PRNEWSWIRE
